Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-19T12:48:05.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:42:49.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study record page appears unchanged, with the same study information and controls visible.
    Difference
    0.1%
    Check dated 2026-10-05T15:00:01.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history, replacing the previous v3.6.6 entry. This reflects a metadata update to the page rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-09-21T20:35:30.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.6.6, was added to the study record history. The previous Revision: v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-31T16:16:50.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The history now shows the latest revision as v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-10T12:50:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.